• レポートコード:GIR-107A12566 • 出版社/出版日:GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、100ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:医療 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、百日咳治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。百日咳治療の種類別市場規模(アジスロマイシン、クラリスロマイシン、エリスロマイシン、その他)、用途別市場規模(子供、大人)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・百日咳治療の市場概要 ・企業情報(企業概要、製品概要、販売量、価格、売上):Sanofi、GSK、Merck、Mitsubishi Tanabe Pharma、Astellas Pharma、Shenzhen KangTai Biological Products、China National Biotec Group、Changchun Changsheng Life Sciences ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年:アジスロマイシン、クラリスロマイシン、エリスロマイシン、その他 ・用途別分析2016年-2026年:子供、大人 ・百日咳治療の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ ・百日咳治療のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア ・百日咳治療のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア ・百日咳治療の南米市場規模2016年-2026年:ブラジル、アルゼンチン ・百日咳治療の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pertussis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pertussis Treatment size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Pertussis Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Pertussis Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Azithromycin
Clarithromycin
Erythromycin
Other
Market segment by Application, can be divided into
Children
Adults
Market segment by players, this report covers
Sanofi
GSK
Merck
Mitsubishi Tanabe Pharma
Astellas Pharma
Shenzhen KangTai Biological Products
China National Biotec Group
Changchun Changsheng Life Sciences
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Pertussis Treatment
1.2 Classification of Pertussis Treatment by Type
1.2.1 Overview: Global Pertussis Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Pertussis Treatment Revenue Market Share by Type in 2020
1.2.3 Azithromycin
1.2.4 Clarithromycin
1.2.5 Erythromycin
1.2.6 Other
1.3 Global Pertussis Treatment Market by Application
1.3.1 Overview: Global Pertussis Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Children
1.3.3 Adults
1.4 Global Pertussis Treatment Market Size & Forecast
1.5 Global Pertussis Treatment Market Size and Forecast by Region
1.5.1 Global Pertussis Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Pertussis Treatment Market Size by Region, (2016-2021)
1.5.3 North America Pertussis Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Pertussis Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Pertussis Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Pertussis Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Pertussis Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pertussis Treatment Market Drivers
1.6.2 Pertussis Treatment Market Restraints
1.6.3 Pertussis Treatment Trends Analysis
2 Company Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Pertussis Treatment Product and Solutions
2.1.4 Sanofi Pertussis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Sanofi Recent Developments and Future Plans
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Pertussis Treatment Product and Solutions
2.2.4 GSK Pertussis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 GSK Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Pertussis Treatment Product and Solutions
2.3.4 Merck Pertussis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Merck Recent Developments and Future Plans
2.4 Mitsubishi Tanabe Pharma
2.4.1 Mitsubishi Tanabe Pharma Details
2.4.2 Mitsubishi Tanabe Pharma Major Business
2.4.3 Mitsubishi Tanabe Pharma Pertussis Treatment Product and Solutions
2.4.4 Mitsubishi Tanabe Pharma Pertussis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Mitsubishi Tanabe Pharma Recent Developments and Future Plans
2.5 Astellas Pharma
2.5.1 Astellas Pharma Details
2.5.2 Astellas Pharma Major Business
2.5.3 Astellas Pharma Pertussis Treatment Product and Solutions
2.5.4 Astellas Pharma Pertussis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Astellas Pharma Recent Developments and Future Plans
2.6 Shenzhen KangTai Biological Products
2.6.1 Shenzhen KangTai Biological Products Details
2.6.2 Shenzhen KangTai Biological Products Major Business
2.6.3 Shenzhen KangTai Biological Products Pertussis Treatment Product and Solutions
2.6.4 Shenzhen KangTai Biological Products Pertussis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Shenzhen KangTai Biological Products Recent Developments and Future Plans
2.7 China National Biotec Group
2.7.1 China National Biotec Group Details
2.7.2 China National Biotec Group Major Business
2.7.3 China National Biotec Group Pertussis Treatment Product and Solutions
2.7.4 China National Biotec Group Pertussis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 China National Biotec Group Recent Developments and Future Plans
2.8 Changchun Changsheng Life Sciences
2.8.1 Changchun Changsheng Life Sciences Details
2.8.2 Changchun Changsheng Life Sciences Major Business
2.8.3 Changchun Changsheng Life Sciences Pertussis Treatment Product and Solutions
2.8.4 Changchun Changsheng Life Sciences Pertussis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Changchun Changsheng Life Sciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pertussis Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Pertussis Treatment Players Market Share
3.2.2 Top 10 Pertussis Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Pertussis Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Pertussis Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Pertussis Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Pertussis Treatment Revenue Market Share by Application (2016-2021)
5.2 Pertussis Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Pertussis Treatment Revenue by Type (2016-2026)
6.2 North America Pertussis Treatment Revenue by Application (2016-2026)
6.3 North America Pertussis Treatment Market Size by Country
6.3.1 North America Pertussis Treatment Revenue by Country (2016-2026)
6.3.2 United States Pertussis Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Pertussis Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Pertussis Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Pertussis Treatment Revenue by Type (2016-2026)
7.2 Europe Pertussis Treatment Revenue by Application (2016-2026)
7.3 Europe Pertussis Treatment Market Size by Country
7.3.1 Europe Pertussis Treatment Revenue by Country (2016-2026)
7.3.2 Germany Pertussis Treatment Market Size and Forecast (2016-2026)
7.3.3 France Pertussis Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Pertussis Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Pertussis Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Pertussis Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Pertussis Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Pertussis Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Pertussis Treatment Market Size by Region
8.3.1 Asia-Pacific Pertussis Treatment Revenue by Region (2016-2026)
8.3.2 China Pertussis Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Pertussis Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Pertussis Treatment Market Size and Forecast (2016-2026)
8.3.5 India Pertussis Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Pertussis Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Pertussis Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Pertussis Treatment Revenue by Type (2016-2026)
9.2 South America Pertussis Treatment Revenue by Application (2016-2026)
9.3 South America Pertussis Treatment Market Size by Country
9.3.1 South America Pertussis Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Pertussis Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Pertussis Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Pertussis Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Pertussis Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Pertussis Treatment Market Size by Country
10.3.1 Middle East & Africa Pertussis Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Pertussis Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Pertussis Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Pertussis Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Pertussis Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Pertussis Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Pertussis Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Pertussis Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Pertussis Treatment Revenue Market Share by Region (2021-2026)
Table 6. Sanofi Corporate Information, Head Office, and Major Competitors
Table 7. Sanofi Major Business
Table 8. Sanofi Pertussis Treatment Product and Solutions
Table 9. Sanofi Pertussis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. GSK Corporate Information, Head Office, and Major Competitors
Table 11. GSK Major Business
Table 12. GSK Pertussis Treatment Product and Solutions
Table 13. GSK Pertussis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Merck Corporate Information, Head Office, and Major Competitors
Table 15. Merck Major Business
Table 16. Merck Pertussis Treatment Product and Solutions
Table 17. Merck Pertussis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Mitsubishi Tanabe Pharma Corporate Information, Head Office, and Major Competitors
Table 19. Mitsubishi Tanabe Pharma Major Business
Table 20. Mitsubishi Tanabe Pharma Pertussis Treatment Product and Solutions
Table 21. Mitsubishi Tanabe Pharma Pertussis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 23. Astellas Pharma Major Business
Table 24. Astellas Pharma Pertussis Treatment Product and Solutions
Table 25. Astellas Pharma Pertussis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Shenzhen KangTai Biological Products Corporate Information, Head Office, and Major Competitors
Table 27. Shenzhen KangTai Biological Products Major Business
Table 28. Shenzhen KangTai Biological Products Pertussis Treatment Product and Solutions
Table 29. Shenzhen KangTai Biological Products Pertussis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. China National Biotec Group Corporate Information, Head Office, and Major Competitors
Table 31. China National Biotec Group Major Business
Table 32. China National Biotec Group Pertussis Treatment Product and Solutions
Table 33. China National Biotec Group Pertussis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Changchun Changsheng Life Sciences Corporate Information, Head Office, and Major Competitors
Table 35. Changchun Changsheng Life Sciences Major Business
Table 36. Changchun Changsheng Life Sciences Pertussis Treatment Product and Solutions
Table 37. Changchun Changsheng Life Sciences Pertussis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Pertussis Treatment Revenue (USD Million) by Players (2019-2021)
Table 39. Global Pertussis Treatment Revenue Share by Players (2019-2021)
Table 40. Breakdown of Pertussis Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Pertussis Treatment Players Head Office, Products and Services Provided
Table 42. Pertussis Treatment Mergers & Acquisitions in the Past Five Years
Table 43. Pertussis Treatment New Entrants and Expansion Plans
Table 44. Global Pertussis Treatment Revenue (USD Million) by Type (2016-2021)
Table 45. Global Pertussis Treatment Revenue Share by Type (2016-2021)
Table 46. Global Pertussis Treatment Revenue Forecast by Type (2021-2026)
Table 47. Global Pertussis Treatment Revenue by Application (2016-2021)
Table 48. Global Pertussis Treatment Revenue Forecast by Application (2021-2026)
Table 49. North America Pertussis Treatment Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Pertussis Treatment Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Pertussis Treatment Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Pertussis Treatment Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Pertussis Treatment Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Pertussis Treatment Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Pertussis Treatment Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Pertussis Treatment Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Pertussis Treatment Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Pertussis Treatment Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Pertussis Treatment Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Pertussis Treatment Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Pertussis Treatment Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Pertussis Treatment Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Pertussis Treatment Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Pertussis Treatment Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Pertussis Treatment Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Pertussis Treatment Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Pertussis Treatment Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Pertussis Treatment Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Pertussis Treatment Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Pertussis Treatment Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Pertussis Treatment Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Pertussis Treatment Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Pertussis Treatment Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Pertussis Treatment Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Pertussis Treatment Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Pertussis Treatment Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Pertussis Treatment Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Pertussis Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Pertussis Treatment Picture
Figure 2. Global Pertussis Treatment Revenue Market Share by Type in 2020
Figure 3. Azithromycin
Figure 4. Clarithromycin
Figure 5. Erythromycin
Figure 6. Other
Figure 7. Pertussis Treatment Revenue Market Share by Application in 2020
Figure 8. Children Picture
Figure 9. Adults Picture
Figure 10. Global Pertussis Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Pertussis Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Pertussis Treatment Revenue Market Share by Region (2016-2026)
Figure 13. Global Pertussis Treatment Revenue Market Share by Region in 2020
Figure 14. North America Pertussis Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Pertussis Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Pertussis Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Pertussis Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Pertussis Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Pertussis Treatment Market Drivers
Figure 20. Pertussis Treatment Market Restraints
Figure 21. Pertussis Treatment Market Trends
Figure 22. Sanofi Recent Developments and Future Plans
Figure 23. GSK Recent Developments and Future Plans
Figure 24. Merck Recent Developments and Future Plans
Figure 25. Mitsubishi Tanabe Pharma Recent Developments and Future Plans
Figure 26. Astellas Pharma Recent Developments and Future Plans
Figure 27. Shenzhen KangTai Biological Products Recent Developments and Future Plans
Figure 28. China National Biotec Group Recent Developments and Future Plans
Figure 29. Changchun Changsheng Life Sciences Recent Developments and Future Plans
Figure 30. Global Pertussis Treatment Revenue Share by Players in 2020
Figure 31. Pertussis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Pertussis Treatment Revenue Market Share in 2020
Figure 33. Global Top 10 Players Pertussis Treatment Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Pertussis Treatment Revenue Share by Type in 2020
Figure 36. Global Pertussis Treatment Market Share Forecast by Type (2021-2026)
Figure 37. Global Pertussis Treatment Revenue Share by Application in 2020
Figure 38. Global Pertussis Treatment Market Share Forecast by Application (2021-2026)
Figure 39. North America Pertussis Treatment Sales Market Share by Type (2016-2026)
Figure 40. North America Pertussis Treatment Sales Market Share by Application (2016-2026)
Figure 41. North America Pertussis Treatment Revenue Market Share by Country (2016-2026)
Figure 42. United States Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Pertussis Treatment Sales Market Share by Type (2016-2026)
Figure 46. Europe Pertussis Treatment Sales Market Share by Application (2016-2026)
Figure 47. Europe Pertussis Treatment Revenue Market Share by Country (2016-2026)
Figure 48. Germany Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Pertussis Treatment Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Pertussis Treatment Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Pertussis Treatment Revenue Market Share by Region (2016-2026)
Figure 56. China Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Pertussis Treatment Sales Market Share by Type (2016-2026)
Figure 63. South America Pertussis Treatment Sales Market Share by Application (2016-2026)
Figure 64. South America Pertussis Treatment Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Pertussis Treatment Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Pertussis Treatment Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Pertussis Treatment Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Pertussis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source